Risk Factors Associated with Antibiotic Exposure Variability in Critically Ill Patients: A Systematic Review

被引:0
|
作者
Gras-Martin, Laura [1 ,2 ,3 ]
Plaza-Diaz, Adrian [1 ,2 ]
Zarate-Tamames, Borja [1 ,2 ]
Vera-Artazcoz, Paula [2 ,3 ,4 ]
Torres, Olga H. [2 ,3 ,5 ]
Bastida, Carla [6 ,7 ]
Soy, Dolors [6 ,7 ]
Ruiz-Ramos, Jesus [1 ,2 ,3 ]
机构
[1] Hosp Santa Creu i St Pau, Pharm Dept, St Antoni Maria Claret 167, Barcelona 08025, Spain
[2] Inst Recerca St Pau IR St PAU, Sat Quinti 77-79, Barcelona 08041, Spain
[3] Univ Autonoma Barcelona, Dept Med, Bellaterra 08193, Spain
[4] Hosp Santa Creu i St Pau, Intens Care Dept, St Antoni Maria Claret 167, Barcelona 08025, Spain
[5] Hosp Samta Creu i St Pau, Internal Med Dept, Geriatr Unit, St Antoni Maria Claret 167, Barcelona 08025, Spain
[6] Hosp Clin Barcelona, Pharm Dept, Div Med, Villarroel 170, Barcelona 08036, Spain
[7] Univ Barcelona, Fac Pharm, Dept Pharmacol, Toxicol & Therapeut Chem, Ave de Joan XXIII 27-31, Barcelona 08028, Spain
来源
ANTIBIOTICS-BASEL | 2024年 / 13卷 / 09期
关键词
pharmacokinetics; pharmacodynamics; critically ill patients; antibiotic; exposure; target attainment; risk factors; RENAL REPLACEMENT THERAPY; CONTINUOUS VENOVENOUS HEMOFILTRATION; INTENSIVE-CARE-UNIT; LOW-EFFICIENCY DIALYSIS; PIPERACILLIN POPULATION PHARMACOKINETICS; VENTILATOR-ASSOCIATED PNEUMONIA; NEGATIVE BACTERIAL-INFECTIONS; ACUTE KIDNEY INJURY; CONTINUOUS-INFUSION; SEPTIC PATIENTS;
D O I
10.3390/antibiotics13090801
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
(1) Background: Knowledge about the behavior of antibiotics in critically ill patients has been increasing in recent years. Some studies have concluded that a high percentage may be outside the therapeutic range. The most likely cause of this is the pharmacokinetic variability of critically ill patients, but it is not clear which factors have the greatest impact. The aim of this systematic review is to identify risk factors among critically ill patients that may exhibit significant pharmacokinetic alterations, compromising treatment efficacy and safety. (2) Methods: The search included the PubMed, Web of Science, and Embase databases. (3) Results: We identified 246 observational studies and ten clinical trials. The most studied risk factors in the literature were renal function, weight, age, sex, and renal replacement therapy. Risk factors with the greatest impact included renal function, weight, renal replacement therapy, age, protein or albumin levels, and APACHE or SAPS scores. (4) Conclusions: The review allows us to identify which critically ill patients are at a higher risk of not reaching therapeutic targets and helps us to recognize the extensive number of risk factors that have been studied, guiding their inclusion in future studies. It is essential to continue researching, especially in real clinical practice and with clinical outcomes.
引用
收藏
页数:27
相关论文
共 50 条
  • [1] Recommended Antibiotic Dosage Regimens in Critically Ill Patients with Augmented Renal Clearance: A Systematic Review
    Silva, Catarina Mendes
    Baptista, Joao Pedro
    Santos, Iolanda
    Martins, Paulo
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2022, 59 (05)
  • [2] A narrative review of predictors for β-lactam antibiotic exposure during empirical treatment in critically ill patients
    Abdulla, Alan
    Ewoldt, Tim M. J.
    Purmer, Ilse M.
    Muller, Anouk E.
    Gommers, Diederik
    Endeman, Henrik
    Koch, Birgit C. P.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2021, 17 (04) : 359 - 368
  • [3] Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review
    Sime, Fekade Bruck
    Roberts, Michael S.
    Peake, Sandra L.
    Lipman, Jeffrey
    Roberts, Jason A.
    ANNALS OF INTENSIVE CARE, 2012, 2
  • [4] Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams
    Goncalves-Pereira, Joao
    Povoa, Pedro
    CRITICAL CARE, 2011, 15 (05):
  • [5] The impact of continuous renal replacement therapy on antibiotic pharmacokinetics in critically ill patients
    Fiore, Marco
    Peluso, Lorenzo
    Taccone, Fabio Silvio
    Hites, Maya
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2021, 17 (05) : 543 - 554
  • [6] Pharmacokinetic variability of beta-lactams in critically ill patients: A narrative review
    Boidin, Clement
    Moshiri, Parastou
    Dahyot-Fizelier, Claire
    Goutelle, Sylvain
    Lefeuvre, Sandrine
    ANAESTHESIA CRITICAL CARE & PAIN MEDICINE, 2020, 39 (01) : 87 - 109
  • [7] Risk Factors for Incontinence-Associated Dermatitis in Critically Ill Patients with Incontinence A Systematic Review and Meta-analysis
    Wang, Guandong
    Wang, Xueying
    Wang, Haibo
    Wang, Liang
    Li, Wenjuan
    JOURNAL OF WOUND OSTOMY AND CONTINENCE NURSING, 2024, 51 (04) : 313 - 323
  • [8] The Relevance of Drug Clearance to Antibiotic Dosing in Critically Ill Patients
    Roberts, Darren M.
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2011, 12 (12) : 2002 - 2014
  • [9] Risk Factors Associated With Pressure Ulcer Formation in Critically Ill Cardiac Surgery Patients A Systematic Review
    Rao, Aditi D.
    Preston, Ave M.
    Strauss, Robyn
    Stamm, Rebecca
    Zalman, Demetra C.
    JOURNAL OF WOUND OSTOMY AND CONTINENCE NURSING, 2016, 43 (03) : 242 - 247
  • [10] Risk factors for colistin-associated nephrotoxicity and mortality in critically ill patients
    Ozkarakas, Huseyin
    Kose, Isil
    Zincircioglu, Ciler
    Ersan, Sibel
    Ersan, Gursel
    Senoglu, Nimet
    Kose, Sukran
    Erbay, Riza Hakan
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2017, 47 (04) : 1165 - 1172